SMC Laboratories is highly regarded worldwide as a consulting CRO that designs studies in line with the demands of pharmaceutical companies and research institutions.
In particular, in the NASH-HCC field, SMC is a highly regarded CRO, because of our unique STAM™ mice.
The results achieved with our STAM™ have been introduced in academic publications as well as scientific conferences.
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
No.85
“Periodontitis promotes hepatocellular carcinoma in Stelic Animal model (STAM) mice” (Sci. Rep., DOI: 10.1038/s41598-024-68422-7, 2024)
VIEW ARTICLE
No.84
“StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis” (Am J Physiol Gastrointest Liver Physiol., DOI: 10.1152/ajpgi.00024.2024, 2024)
VIEW ARTICLE
No.83
“A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models” (Nat Biotechnol., DOI: 10.1038/s41587-024-02143-0, 2024)
VIEW ARTICLE